Clinical trial
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
NCT05809752
Study timeline
Study start (actual)2023-08-22Date precision: day
Registry last updated2026-09-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Leptomeningeal Diseaseunresolved
Triple Negative Breast Cancerunresolved
HER2-positive Breast Cancerunresolved
Interventions
Dendritic Cell VaccineBIOLOGICAL
Sponsors & collaborators
United States Department of Defensecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05809752 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.